News

May 4, 2012 - Angioslide Ltd., a provider of embolic capture angioplasty solutions, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its new 3x100 mm...

May 4, 2012 - A new balloon catheter system could advance the endovascular approach to treating obstructed...

May 4, 2012 - SMT Research & Development Ltd. (SMT) announced the addition of three key executives to its management team, including a new CEO, CFO and chief medical officer, plus two...

May 4, 2012 - The U.S. Food and Drug Administration (FDA) has approved the premarket approval application (PMA) for the Medinol Ltd. Presillion plus cobalt chromium (CoCr) coronary...

May 4, 2012 - Medtronic Inc. announced six-month pooled outcomes from randomized and crossover patients in the Symplicity HTN-2 clinical trial following renal denervation with the Symplicity renal...

May 2, 2012 — Vessix Vascular Inc. announced this week that it has received CE mark approval for its V2 Renal Denervation System for the treatment of hypertension. Renal denervation is a...

May 1, 2012 – The Centers for Medicare and Medicaid Services (CMS) announced today it will now cover transcatheter aortic valve replacement (TAVR) for Medicare...

May 1, 2012 — Theragenics Corp. announced that Galt Medical, a wholly-owned subsidiary of Theragenics, has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Galt VTI...

April 26, 2012 — Interventional cardiologists can and should lead efforts to improve quality, cut costs and ensure appropriate use of procedures. Elliott Fisher, M.D., MPH, professor of medicine...

April 26, 2012 - The timing of treatment when someone is having a heart attack can mean the difference between life and death. To help save lives, the American Heart Association and the Society of...

April 24, 2012 - Boston Scientific Corp. announces CE mark and European market launch of the Emerge PTCA Dilatation Catheter. The Emerge catheter is a next-generation pre-dilatation balloon...

April 24, 2012 - SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO) — a platform for the percutaneous transcatheter closure of a heart defect...

April 23, 2012 - Abbott and St. Jude Medical announced ChoiceAlliance, a multi-year joint initiative that provides mutual U.S. customers
access to a robust portfolio of interventional...

April 23, 2012 - Boston Scientific Corp. announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus Aortic Valve System...

April 23, 2012 - CircuLite Inc. announced that updated clinical data related to the Synergy miniature ventricular support system was presented in two oral presentations and one poster session at...

April 20, 2012 — VasoStitch will be featuring its technology at EuroPCR, Europe’s largest interventional cardiology scientific meeting, May 17, in Paris.

April 19, 2012 - St. Jude Medical Inc., a global medical device company, announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) and the launch of the Trifecta...

April 19, 2012 - The FDA received a report from a hospital that 16 patients had developed hospital-acquired infections with the bacteria Pseudomonas aeruginosa following an examination with...

April 19, 2012 — Spherix Inc. announced results from its recently completed studies using near-infrared spectroscopy on autopsy samples from humans who had confirmed cardiovascular disease....

April 17, 2012 –– Expanding its commitment to developing innovative treatments for cardiovascular disease and the evidence to support their adoption, Medtronic announced the start of the Medtronic...

April 17, 2012 - Approximately 6 million Americans have brain aneurysms, a condition that occurs when a weak or thin spot develops on a blood vessel in the brain causing it to balloon. Often,...

April 12, 2012 – Abbott announced approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next-generation Xience Prime Everolimus-Eluting Coronary Stent System for the...

April 17, 2012 - On April 9, 2012, the FDA's Center for Devices and Radiological Health (CDRH) launched its second version of the Innovation Pathway, called "Innovation Pathway 2.0." This program...

April 17, 2012 – SynCardia Systems Inc., manufacturer of the world’s first and only FDA-, Health Canada- and CE-approved Total Artificial Heart, announced that the U.S. Food and Drug...

April 16, 2012 - 480 Biomedical announced that it has initiated the first human trial of its groundbreaking Stanza self-expanding bioresorbable scaffold for the treatment of peripheral artery...

April 12, 2012 - Abiomed Inc., a provider of heart support technologies, announced it has received CE marking approval in the European
Union to market the Impella cVAD device, a new...

April 12, 2012 – Terumo Interventional Systems recently announced the nationwide availability of the Azur D35 Framing Coil, the first truly detachable coil that precisely frames the targeted area...

Philips Healthcare recently installed an Allura Xper FD 20/20 biplane angiography X-ray system at Primary Children's Medical Center in Salt Lake City, with a National Basketball Association (NBA)...

April 12, 2012 - Edwards Lifesciences Corp. said a U.S. Food and Drug Administration (FDA) advisory panel will review the company's request to expand the indication for the Sapien transcatheter...

April 12, 2012 — The Maryland General Assembly set a high bar for the nation and showed its commitment to patients by passing legislation establishing an independent review of the placement of...

ReCor Medical disclosed updated data for the REDUCE First-In-Man clinical study of its CE-marked Paradise (percutaneous renal denervation system) ultrasound platform, which is...

April 9, 2012 — Thoratec and the U.S. Food and Drug Adminstration (FDA) announced a recent Class 1 recall of the HeartMate II left ventricular assist device (LVAD) because detachment of the bend...

April 9, 2012 — Healthcare supply contracting company Novation released its 2012 Diagnostic Imaging Watch report. Peer reviewed by members of Novation's Diagnostic Imaging...

April 6, 2012 — Crux Biomedical announced that a recently completed pivotal trial of its Crux Vena Cava Filter (VCF) System with bi-directional retrieval was presented at the 2012 Society of...

April 5, 2012 —Maquet and Siemens Healthcare announced they will collaborate closely to introduce a combined system for diagnostics and surgical procedures. The first systems will be delivered and...

April 5, 2012 — The American College of Cardiology (ACC) released a list of “Five Things Physicians and Patients Should Question” in cardiology as part of Choosing Wisely, an...

April 4, 2012 — Medtronic Inc. announced that the Symplicity renal denervation system provides safe, significant and sustained blood pressure reduction up to three years in patients with treatment...

April 4, 2012 — Edwards Lifesciences Corp. reported that longer-term results (≥ 2 years) from the high-risk Cohort A of the PARTNER Trial – a randomized comparison of patients treated with either...

April 4, 2012 — Medrad (Bayer) recently introduced the Mark 7 Arterion angiographic contrast injection system. The system is much smaller, lighter-weight, more ergonomic and easier to maneuver...

Incidences of renal complications, specifically acute renal failure (ARF) and new hemodialysis (HD), continue to increase significantly among Medicare beneficiaries (MB) admitted for percutaneous...

A new comparative effectiveness study found older adults with stable coronary disease who underwent coronary artery bypass graft had better long-term survival than those who underwent percutaneous...

Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted...

Patients who underwent transcatheter aortic valve implantation (TAVI) at experienced medical centers had significant improvement in valve function as well as low mortality and stroke rates at 30...

March 29, 2012 — Non-cardiac co-morbidities such as chronic obstructive pulmonary disease, chronic kidney disease and frailty are the main predictors of late mortality after transcatheter aortic...

Two-year follow-up data from the pivotal PLATINUM Workhorse trial comparing the safety and effectiveness of the Promus Element and Xience V everolimus-eluting coronary stents demonstrated superior...

March 29, 2012 — In the second year of an ongoing trial, the Resolute zotarolimus-eluting stent (Medtronic) achieved a low rate of stent thrombosis, cardiac death, target vessel heart attack and...

March 29, 2012 — Adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly reduces the risk of recurrent cardiovascular events in a specific group of...

The American College of Cardiology (ACC) 2012 Scientific Session, held March 24-27 in Chicago, was the first major cardiology show this year for vendors to display their latest innovations. A...

March 29, 2012 — St. Jude Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance for multiple enhancements to its PressureWire Fractional Flow Reserve (FFR)...

March 29, 2012 — Siemens Healthcare recently expanded its solutions portfolio by offering the RaySafe i2 personal dosimetry system as an accessory for all Siemens Artis zee angiography systems. By...

GE Healthcare unveiled two recently U.S. Food and Drug Administration (FDA)-cleared angiography systems offering mobility and advanced imaging for interventional cardiology at the American College...

New evidence shows that with appropriate preparation, angioplasty can be safely and effectively performed at community hospitals without on-site cardiac surgery units. This was according to data...

Coronary angiography is unable to accurately predict the severity of vessel...

March 27, 2012 – Researchers found the antiplatelet drug abciximab significantly decreased damage to the heart muscle in patients with ST-segment-elevation myocardial infarction (STEMI), the most...

Biodegradable polymer drug-eluting stents (DES) provide better long-term safety and efficacy than durable polymer DES, according to findings from an analysis of three major clinical trials — ISAR-...

March 26, 2012 — Maquet announced positive long-term mortality results from the Balloon Pump-Assisted Coronary Intervention Study (BCIS-1), which evaluated the effect on major complications and...

March 23, 2012 — Improving the ability to diagnose cardiac disease with advanced ultrasound imaging, Toshiba America Medical Systems Inc. will showcase the newest additions to its ultrasound...

March 22, 2012 — Infraredx Inc. announced that its TVC Imaging System for the true vessel characterization of coronary artery disease will be featured in 11 oral and poster presentations,...

Addressing concerns over radiation from cardiac imaging and procedures, the American College of Cardiology Foundation (ACCF), Duke University Clinical Research Institute (DCRI) and American Heart...

March 20, 2012 – The Society for Cardiovascular Angiography and Interventions (SCAI) published a first-of-its-kind paper defining best practices in the cardiac catheterization laboratory, commonly...

March 20, 2012 - MarBlue Medical announced the global product launch of its CE-marked drug-eluting balloon (DEB) Protege as well as its CoCr stent on DEB Pioneer. The full market launch of the new...

Jack Miller, 62, is probably the only politician in America who smiles when people call him “heartless.” Four months ago, doctors at Virginia Commonwealth University (VCU) Medical Center in...

March 16, 2012 -- Kensey Nash Corp. today announced that the company has entered into a $39 million settlement agreement with St. Jude Medical, which resolves all disputes between the two...

March 16, 2012 — The U.S. Food and Drug Administration (FDA) approved the premarket approval (PMA) application for the Covidien EverFlex self-expanding peripheral stent system.

March 16, 2012 — Epocrates is releasing two new, free mobile device applications for cardiologists during the American College of Cardiology 2012 meeting.

March 16, 2012 - Stroke survivors who like art have a significantly higher quality of life than those who do not, according to new research. Patients who appreciated music, painting and...

March 16, 2012 – Medistim’s VeriQ system, which uses ultrasound to assess graft blood flow during coronary artery bypass graft (CABG) surgery, recently withstood the clinical scrutiny of the...

March 16, 2012 - Depression increases the risk of death in patients who have a coronary stent implanted. After seven years of follow up, depressed patients were 1.5 times more likely to have died...

March 15, 2012 — According to Millennium Research Group (MRG) the interventional cardiology (IC) market in Pakistan, Saudi Arabia, South Africa and Turkey will reach a value of more than $460...

March 13, 2012 — Asahi Kasei Corp.  and Zoll Medical Corp. jointly announced that Asahi Kasei will acquire Zoll for approximately $2.21 billion.

March 12, 2012 — Siemens Healthcare announced shipment of the Acuson S1000 ultrasound system, a premium ultrasound platform. The Acuson S1000 system expands access to imaging performance at a very...

March 9, 2012 - Researchers say venom from the green mamba snake may aid in the preservation of cardiac and renal function following serious cardiovascular events, such as heart attack and acute...

March 9, 2012 — Avinger Inc. announced the enrollment of the first U.S. patient in the CONNECT II global clinical trial evaluating the safety and efficacy of Ocelot. The device is the first...

March 8, 2012 — Edwards Lifesciences Corp. reported March 3 it filed its official response to the Centers for Medicare and Medicaid Services (CMS) on its proposed national coverage determination (...